Literature DB >> 34177376

Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data.

Md Tuhin Sheikh1, Joseph G Ibrahim2, Jonathan A Gelfond3, Wei Sun4, Ming-Hui Chen1.   

Abstract

This research is motivated from the data from a large Selenium and Vitamin E Cancer Prevention Trial (SELECT). The prostate specific antigens (PSAs) were collected longitudinally, and the survival endpoint was the time to low-grade cancer or the time to high-grade cancer (competing risks). In this article, the goal is to model the longitudinal PSA data and the time-to-prostate cancer (PC) due to low- or high-grade. We consider the low-grade and high-grade as two competing causes of developing PC. A joint model for simultaneously analysing longitudinal and time-to-event data in the presence of multiple causes of failure (or competing risk) is proposed within the Bayesian framework. The proposed model allows for handling the missing causes of failure in the SELECT data and implementing an efficient Markov chain Monte Carlo sampling algorithm to sample from the posterior distribution via a novel reparameterization technique. Bayesian criteria, ΔDICSurv, and ΔWAICSurv, are introduced to quantify the gain in fit in the survival sub-model due to the inclusion of longitudinal data. A simulation study is conducted to examine the empirical performance of the posterior estimates as well as ΔDICSurv and ΔWAICSurv and a detailed analysis of the SELECT data is also carried out to further demonstrate the proposed methodology.

Entities:  

Keywords:  DIC; SELECT data; WAIC; cause-specific competing risks model; mixed effects model; reparametrization

Year:  2020        PMID: 34177376      PMCID: PMC8225229          DOI: 10.1177/1471082X20944620

Source DB:  PubMed          Journal:  Stat Modelling        ISSN: 1471-082X            Impact factor:   2.039


  16 in total

1.  Bayesian analysis for generalized linear models with nonignorably missing covariates.

Authors:  Lan Huang; Ming-Hui Chen; Joseph G Ibrahim
Journal:  Biometrics       Date:  2005-09       Impact factor: 2.571

2.  An approach to joint analysis of longitudinal measurements and competing risks failure time data.

Authors:  Robert M Elashoff; Gang Li; Ning Li
Journal:  Stat Med       Date:  2007-06-30       Impact factor: 2.373

3.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.

Authors:  C L Faucett; D C Thomas
Journal:  Stat Med       Date:  1996-08-15       Impact factor: 2.373

4.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

5.  Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.

Authors:  Amit M Algotar; Steven P Stratton; James Ranger-Moore; M Suzanne Stratton; C H Hsu; Frederick R Ahmann; Raymond B Nagle; Patricia A Thompson
Journal:  Am J Mens Health       Date:  2011-05

6.  A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects.

Authors:  Xin Huang; Gang Li; Robert M Elashoff; Jianxin Pan
Journal:  Lifetime Data Anal       Date:  2010-06-12       Impact factor: 1.588

7.  Obesity-PSA relationship: a new formula.

Authors:  I A Hekal; E I Ibrahiem
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-12-22       Impact factor: 5.554

8.  Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer.

Authors:  Loïc Ferrer; Virginie Rondeau; James Dignam; Tom Pickles; Hélène Jacqmin-Gadda; Cécile Proust-Lima
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

9.  JMFit: A SAS Macro for Joint Models of Longitudinal and Survival Data.

Authors:  Danjie Zhang; Ming-Hui Chen; Joseph G Ibrahim; Mark E Boye; Wei Shen
Journal:  J Stat Softw       Date:  2016-07-11       Impact factor: 6.440

10.  A Bayesian approach to joint analysis of longitudinal measurements and competing risks failure time data.

Authors:  Wenhua Hu; Gang Li; Ning Li
Journal:  Stat Med       Date:  2009-05-15       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.